Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Techne Corp - Common Stock (NQ:TECH)

56.87 +3.04 (+5.65%)
Streaming Delayed Price Updated: 9:33 AM EDT, Apr 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Government Stocks
News headline image
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking a... 
Via StockStory
Topics Economy
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Bio-Techne Corp (NASDAQ:TECH) Passes Key Quality Investing Screen ↗
Via Chartmill
Bio-Techne Corp (NASDAQ:TECH) Reports Q2 Earnings Beat, Meets Revenue Forecasts ↗
Via Chartmill
Topics Earnings
Stay informed with the top movers within the S&P500 index on Monday. ↗
Via Chartmill
News headline image
Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake? ↗
Bio-Techne develops specialized reagents and diagnostic solutions for global research and clinical markets in the life sciences sector. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Cash-Producing Stocks with Open Questions
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
Via StockStory
News headline image
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea... 
Via StockStory
Topics Economy
News headline image
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
Bio-Techne trades at $56.99 and has moved in lockstep with the market. Its shares have returned 7.7% over the last six months while the S&P 500 has gained 5.... 
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Small-Cap Stocks We Keep Off Our Radar
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Topics Economy
News headline image
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
News headline image
1 Profitable Stock to Target This Week and 2 We Avoid
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
Are AMZN Shares Poised For A 9-Day Losing Streak? Here’s What Retail Thinks ↗
Amazon.com stock has lost about 17.5% of its value in the last one month, even as the company’s shares hover near their lowest level since May 23, 2025. 
Via Stocktwits
Topics Artificial Intelligence Economy
News headline image
3 Profitable Stocks with Open Questions
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
News headline image
5 Insightful Analyst Questions From Bio-Techne’s Q4 Earnings Call
Bio-Techne’s fourth quarter was defined by flat revenue performance, yet the company exceeded Wall Street’s expectations on both top and bottom lines, prompting a positive market response. Management... 
Via StockStory
Topics Earnings
News headline image
TECH Q4 Deep Dive: Margin Expansion and Flat Revenue Amid Mixed End Markets
Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46... 
Via StockStory
Wednesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
Bio-Techne (TECH) Q2 2026 Earnings Call Transcript ↗
Bio-Techne (TECH) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Bio-Techne (NASDAQ:TECH) Surprises With Q4 CY2025 Sales
Life sciences company Bio-Techne (NASDAQ:TECH) reported Q4 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $295.9 million. Its non-GAAP profit of $0.46 per... 
Via StockStory
News headline image
Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect
Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market open. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Unpopular Stocks That Concern Us
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
News headline image
3 Cash-Producing Stocks That Fall Short
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Picks and Shovels of the Bio-Revolution: A Deep Dive into Bio-Techne Corporation (TECH)
Today’s Date: January 22, 2026 Introduction In the complex ecosystem of biotechnology, where breakthrough drugs often dominate the headlines, the companies providing the fundamental tools—the "picks... 
Via Finterra
Topics Regulatory Compliance Supply Chain
News headline image
1 High-Flying Stock for Long-Term Investors and 2 That Underwhelm
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,... 
Via StockStory
Movers and shakers in today's after-hours session for S&P500 stocks? ↗
Via Chartmill
News headline image
3 Small-Cap Stocks We Keep Off Our Radar
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
3 Reasons to Avoid TECH and 1 Stock to Buy Instead
Bio-Techne’s 21% return over the past six months has outpaced the S&P 500 by 10.9%, and its stock price has climbed to $62.36 per share. This performance may have investors wondering how to approach... 
Via StockStory
Topics Stocks Supply Chain
News headline image
1 S&P 500 Stock with Exciting Potential and 2 We Question
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Bio-Techne (NASDAQ:TECH) and... 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.